# Halaven

NDC: 62856-389
Generic name: eribulin mesylate
Labeler / Manufacturer: Eisai Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20101115

FDA application: NDA201532

## Active ingredients

- ERIBULIN MESYLATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62856-389"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62856-389
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822